Correlation Between Holloman Energy and Sunshine Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Holloman Energy and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Holloman Energy and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Holloman Energy Corp and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on Holloman Energy and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Holloman Energy with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Holloman Energy and Sunshine Biopharma.

Diversification Opportunities for Holloman Energy and Sunshine Biopharma

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Holloman and Sunshine is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Holloman Energy Corp and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Holloman Energy is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Holloman Energy Corp are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Holloman Energy i.e., Holloman Energy and Sunshine Biopharma go up and down completely randomly.

Pair Corralation between Holloman Energy and Sunshine Biopharma

If you would invest  7.70  in Sunshine Biopharma Warrant on August 28, 2024 and sell it today you would earn a total of  13.30  from holding Sunshine Biopharma Warrant or generate 172.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Holloman Energy Corp  vs.  Sunshine Biopharma Warrant

 Performance 
       Timeline  
Holloman Energy Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Holloman Energy Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Holloman Energy is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Sunshine Biopharma 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma Warrant are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating primary indicators, Sunshine Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Holloman Energy and Sunshine Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Holloman Energy and Sunshine Biopharma

The main advantage of trading using opposite Holloman Energy and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Holloman Energy position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.
The idea behind Holloman Energy Corp and Sunshine Biopharma Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments